These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26309071)

  • 41. Drug sales bring huge profits, and scrutiny, to cancer doctors: insurers and experts see high costs and conflicts.
    Abelson R
    N Y Times Web; 2003 Jan; ():A1, 18. PubMed ID: 12647757
    [No Abstract]   [Full Text] [Related]  

  • 42. Pricing pain: relief in sight on drug costs?
    J Am Health Policy; 1992; 2(6):28-31. PubMed ID: 10122415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncology drug shortages drive cost of care up.
    Manag Care; 2013 Sep; 22(9):44. PubMed ID: 24167837
    [No Abstract]   [Full Text] [Related]  

  • 44. The development of a value based pricing index for new drugs in metastatic colorectal cancer.
    Dranitsaris G; Truter I; Lubbe MS
    Eur J Cancer; 2011 Jun; 47(9):1299-304. PubMed ID: 21493060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Value in Oncology: It Is in the Eyes of the Beholder.
    Nabhan C; Phillips EG; Feinberg BA
    J Natl Compr Canc Netw; 2019 Jan; 17(1):2-5. PubMed ID: 30659123
    [No Abstract]   [Full Text] [Related]  

  • 46. [Methodology of pharmacoeconomic studies in oncology].
    Ballatori E
    Recenti Prog Med; 2008 Jan; 99(1):42-7. PubMed ID: 18389873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical application of drugs with emphasis on more efficacy and lower costs].
    Xie H; Zhou H
    Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):3-4. PubMed ID: 7600317
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy, safety, and cost of new anticancer drugs. Price needs to be evaluated against effectiveness.
    Messori A; Trippoli S; Vaiani M
    BMJ; 2002 Nov; 325(7375):1302; author reply 1302. PubMed ID: 12463189
    [No Abstract]   [Full Text] [Related]  

  • 49. Communicating with patients about chemotherapy costs.
    de Lemos ML
    J Clin Oncol; 2007 May; 25(15):2142; author reply 2142. PubMed ID: 17513825
    [No Abstract]   [Full Text] [Related]  

  • 50. Paying a high price for cancer drugs.
    Lancet; 2015 Aug; 386(9992):404. PubMed ID: 26251376
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
    Kocs D; Fendrick AM
    Am J Manag Care; 2003 May; 9(5):393-400; quiz 401-2. PubMed ID: 12744301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug pricing and value in oncology.
    Danzon PM; Taylor E
    Oncologist; 2010; 15 Suppl 1():24-31. PubMed ID: 20237214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. US gets lower return on its cancer drug spending, study finds.
    McCarthy M
    BMJ; 2016 May; 353():i2494. PubMed ID: 27142646
    [No Abstract]   [Full Text] [Related]  

  • 54. Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking Value.
    Serritella AV; Strohbehn GW; Goldstein DA; Lichter AS; Ratain MJ
    Clin Pharmacol Ther; 2020 Sep; 108(3):487-493. PubMed ID: 32298471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pharmacoeconomic modeling approach to estimate a value-based price for new oncology drugs in Europe.
    Dranitsaris G; Ortega A; Lubbe MS; Truter I
    J Oncol Pharm Pract; 2012 Mar; 18(1):57-67. PubMed ID: 21382915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The shortage of essential chemotherapy drugs in the United States.
    Gatesman ML; Smith TJ
    N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
    [No Abstract]   [Full Text] [Related]  

  • 57. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
    Low E;
    J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
    [No Abstract]   [Full Text] [Related]  

  • 58. Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer.
    Reed SD; Schulman KA
    Value Health; 2009; 12(5):637-40. PubMed ID: 19473336
    [No Abstract]   [Full Text] [Related]  

  • 59. United healthcare, five oncology practices try bundled payments.
    Goozner M
    J Natl Cancer Inst; 2011 Jan; 103(1):8-10. PubMed ID: 21169535
    [No Abstract]   [Full Text] [Related]  

  • 60. Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World.
    Goldstein DA; Sarfaty M
    Oncologist; 2016 Aug; 21(8):907-9. PubMed ID: 27384235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.